News
Displaying 311–320 of 504
-
Foundation Fighting Blindness Appoints Judy Taylor Vice President, Development
Foundation NewsMs. Taylor brings over twenty-five years of successful non-profit experience, including executive-level positions, to Foundation
-
Sustained Suppression of VEGF: Looking Forward and Looking Back
Research NewsThe results of the LADDER trial demonstrate a major step forward but introduce many questions.
-
Gene Therapy Trials for Wet Age-Related Macular Degeneration
Research NewsAfter a series of failed trials, current research suggests that the next generation of gene therapies for wet age-related macular degeneration holds promise. Learn how investigators are inducing the body’s cells to administer their own therapeutic response to disease activity.
-
The Foundation’s Contributions to Genetic Research Published in Peer-Reviewed Journal
Research NewsThe nonprofit has emerged as a driving force in genetic research and treatment development for inherited retinal diseases.
-
SparingVision Gets EU Funding Boost for Development of Cross-Cutting Gene Therapy
Research NewsA clinical trial for the treatment, designed to preserve cone photoreceptors, is planned in the US and Europe in 2020.
-
The Retina is a Proving Ground for a Broad Range of Neurological Therapies
Research NewsRetinal research paves the way for new treatments for the entire neurological system.
-
FDA Wins Case against Stem-Cell Clinic that Blinded Patients with Bogus Treatment
Research NewsA federal court ruled that the FDA has regulatory authority over these stem-cell procedures and the power to halt them.
-
Tackling the Next Gene Therapy Challenge: Autosomal Dominant Diseases
Foundation NewsA discussion of strategies concerning the development of autosomal dominant disease therapies at the Translational Research Acceleration Program (TRAP) in November 2013.
-
Dr. Don Zack Honored for Research Contributions by ARVO and the Foundation Fighting Blindness
Research NewsDr. Zack is a member of the Foundation’s Scientific Advisory Board and chairs its Cellular Molecular Mechanisms of Disease study section.
-
Research News
Eye Bonds provide the opportunity to advance, and accelerate development for, more promising treatments into and through clinical trials and out to the people who need them.
